Surgery, wound healing, and metastasis: recent insights and clinical implications.

BACKGROUND Surgery-induced acceleration of tumour growth has been observed since several centuries. METHODS We reviewed recent insights from in vitro data, animal experimentation, and clinical studies on how surgery-induced wound healing or resection of a primary cancer influences the tumour-host ecosystem in patients harbouring minimal residual or metastatic disease. RESULTS Most of the growth factors, chemokines, and cytokines orchestrating surgical wound healing promote tumour growth, invasion, or angiogenesis. In addition, resection of a primary tumour may accelerate synchronous metastatic growth. In the clinical setting, indirect evidence supports the relevance of the above findings. Randomized clinical trials are underway comparing resection versus observation in metastatic breast and colon cancer with asymptomatic primary tumours. CONCLUSIONS In depth knowledge of how surgical intervention alters the tumour-host-metastasis communicating ecosystems could have important implications for clinical decision making in patients with synchronous metastatic disease and for the design and timing of multimodality treatment strategies.

[1]  B. Rollins,et al.  Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice. , 2001, The American journal of pathology.

[2]  C. Heldin,et al.  Regulation of EMT by TGFβ in cancer , 2012, FEBS letters.

[3]  Angel F. Lopez,et al.  The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease. , 2009, Blood.

[4]  A. Sood,et al.  Surgical Stress Promotes Tumor Growth in Ovarian Carcinoma , 2009, Clinical Cancer Research.

[5]  J. Van Damme,et al.  The role of CXC chemokines and their receptors in cancer. , 2008, Cancer letters.

[6]  D. O'Leary,et al.  TLR-4 Signalling Accelerates Colon Cancer Cell Adhesion via NF-κB Mediated Transcriptional Up-Regulation of Nox-1 , 2012, PloS one.

[7]  K. Camphausen,et al.  Radiation therapy to a primary tumor accelerates metastatic growth in mice. , 2001, Cancer research.

[8]  C. Boselli,et al.  Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer. , 2012, The Cochrane database of systematic reviews.

[9]  L. DiPietro,et al.  Complex roles for VEGF in dermal wound healing , 2011, The Journal of investigative dermatology.

[10]  C. V. D. van de Velde,et al.  Quality assurance in surgical oncology: The tale of the Dutch Rectal Cancer TME trial , 2007, Journal of surgical oncology.

[11]  N. Hyman,et al.  Colorectal Resection is Associated With Persistent Proangiogenic Plasma Protein Changes: Postoperative Plasma Stimulates In Vitro Endothelial Cell Growth, Migration, and Invasion , 2009, Annals of Surgery.

[12]  C. Dejong,et al.  The liver-first approach for synchronous colorectal liver metastasis: a 5-year single-centre experience. , 2011, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[13]  M. Sticherling,et al.  Bioactive interleukin-8 is expressed in wounds and enhances wound healing. , 2000, The Journal of surgical research.

[14]  J. Segall,et al.  A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. , 2000, Cancer research.

[15]  C. Arteaga,et al.  The epidermal growth factor receptor-tyrosine kinase: a promising therapeutic target in solid tumors. , 2003, Seminars in oncology.

[16]  W. Mackillop,et al.  Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. , 2011, JAMA.

[17]  S. Indraccolo,et al.  The angiogenic switch: implications in the regulation of tumor dormancy. , 2009, Current molecular medicine.

[18]  G. Ashcroft,et al.  Tumor necrosis factor‐alpha (TNF‐α) is a therapeutic target for impaired cutaneous wound healing , 2012, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[19]  R. Whelan,et al.  Minimally invasive colorectal resection is associated with a rapid and sustained decrease in plasma levels of epidermal growth factor (EGF) in the colon cancer setting , 2010, Surgical Endoscopy.

[20]  D. Jeffe,et al.  Surgical Removal of the Primary Tumor Increases Overall Survival in Patients With Metastatic Breast Cancer: Analysis of the 1988–2003 SEER Data , 2007, Annals of Surgical Oncology.

[21]  W. De Neve,et al.  Does ionizing radiation stimulate cancer invasion and metastasis? , 2008, Bulletin du cancer.

[22]  Mayo,et al.  Accelerated growth of testicular cancer after cytoreductive surgery , 1980 .

[23]  T G Cotter,et al.  Excisional surgery for cancer cure: therapy at a cost. , 2003, The Lancet. Oncology.

[24]  B. Morgan,et al.  Epidermal stem cells arise from the hair follicle after wounding , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  C. V. D. van de Velde,et al.  Quality assurance in surgical oncology: The tale of the Dutch Rectal Cancer TME trial , 2008, Journal of surgical oncology.

[26]  W. Jiang,et al.  The molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing. , 2006, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[27]  Albrecht Schwab,et al.  Directional Cell Migration and Chemotaxis in Wound Healing Response to PDGF-AA are Coordinated by the Primary Cilium in Fibroblasts , 2010, Cellular Physiology and Biochemistry.

[28]  R. Galiano,et al.  Macrophage colony-stimulating factor accelerates wound healing and upregulates TGF-beta1 mRNA levels through tissue macrophages. , 1997, The Journal of surgical research.

[29]  R. Demicheli,et al.  Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour , 2004, Breast Cancer Research.

[30]  Bethan Psaila,et al.  The metastatic niche: adapting the foreign soil , 2009, Nature Reviews Cancer.

[31]  S. Werner,et al.  Activin enhances skin tumourigenesis and malignant progression by inducing a pro-tumourigenic immune cell response , 2011, Nature communications.

[32]  W. Schatten An experimental study of postoperative tumor metastases. I. Growth of pulmonary metastases following total removal of primary leg tumor , 1958, Cancer.

[33]  J. Schumacher,et al.  Chapter 27 – Anesthesia and Analgesia , 2006 .

[34]  L. Akslen,et al.  Role of Angiogenesis in Human Tumor Dormancy: Animal Models of the Angiogenic Switch , 2006, Cell cycle.

[35]  Qingbo Xu,et al.  Bone marrow resident and circulating progenitor cells in patients undergoing cardiac surgery. , 2010, The Annals of thoracic surgery.

[36]  J. Seto Increased Metabolic Activity of Indolent Liver Metastases After Resection of a Primary Colorectal Tumor , 2008, Journal of Nuclear Medicine.

[37]  O. Sansom,et al.  Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. , 2012, The Journal of clinical investigation.

[38]  G. Vlastos,et al.  Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[40]  M. Pollak,et al.  The Type 1 Insulin-Like Growth Factor Receptor Pathway , 2008, Clinical Cancer Research.

[41]  R. Reznek,et al.  Cancer of unknown primary site. , 2008, Clinical medicine.

[42]  J. Sleeman,et al.  The metastatic niche and stromal progression , 2012, Cancer and Metastasis Reviews.

[43]  M. DeRuiter,et al.  Causes of fecal and urinary incontinence after total mesorectal excision for rectal cancer based on cadaveric surgery: a study from the Cooperative Clinical Investigators of the Dutch total mesorectal excision trial. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  Bingham Ja Letter: Lower oesophageal sphincter. , 1974 .

[45]  M. Mareel,et al.  Cancer invasion and metastasis: interacting ecosystems , 2009, Virchows Archiv.

[46]  M. Ewertz,et al.  Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG) , 2005, British Journal of Cancer.

[47]  R. Demicheli,et al.  Recurrence Dynamics for Non–Small-Cell Lung Cancer: Effect of Surgery on the Development of Metastases , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[48]  D. Hume,et al.  Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. , 2012, Blood.

[49]  K. Mokbel,et al.  The effect of surgical wounding on tumour development. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[50]  A. Bosserhoff,et al.  CTGF is overexpressed in malignant melanoma and promotes cell invasion and migration , 2011, British Journal of Cancer.

[51]  N. Kemeny,et al.  Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  N Gunduz,et al.  Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. , 1983, Cancer research.

[53]  K. Greiner,et al.  "Cutting" on cancer: attitudes about cancer spread and surgery among primary care patients in the U.S.A. , 2011, Social science & medicine.

[54]  J. van Marle,et al.  Surgery-induced reactive oxygen species enhance colon carcinoma cell binding by disrupting the liver endothelial cell lining , 2011, Gut.

[55]  Antoni Castells,et al.  The Long-term Results of a Randomized Clinical Trial of Laparoscopy-assisted Versus Open Surgery for Colon Cancer , 2008, Annals of surgery.

[56]  R K Jain,et al.  Primary tumor size-dependent inhibition of angiogenesis at a secondary site: an intravital microscopic study in mice. , 1998, Cancer research.

[57]  S. Pizzo,et al.  Angiostatin's molecular mechanism: Aspects of specificity and regulation elucidated , 2005, Journal of cellular biochemistry.

[58]  T. Cotter,et al.  Surgical Injury Enhances the Expression of Genes That Mediate Breast Cancer Metastasis to the Lung , 2010, Annals of surgery.

[59]  J. Folkman,et al.  Tumor dormancy due to failure of angiogenesis: role of the microenvironment , 2008, Clinical & Experimental Metastasis.

[60]  P. Carli,et al.  Immediate local and regional recurrence after the excision of a polypoid melanoma: tumor dormancy or tumor activation? , 2003, Dermatologic Surgery.

[61]  J Alfred Witjes,et al.  The Time-Resolved Fluorescence-Based PCA3 Test on Urinary Sediments after Digital Rectal Examination; a Dutch Multicenter Validation of the Diagnostic Performance , 2007, Clinical Cancer Research.

[62]  B. Fisher From Halsted to prevention and beyond: advances in the management of breast cancer during the twentieth century. , 1999, European journal of cancer.

[63]  Mario Morino,et al.  Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. , 2009, The Lancet. Oncology.

[64]  O. Finn Human tumor antigens, immunosurveillance, and cancer vaccines , 2006, Immunologic research.

[65]  A. Sood,et al.  Stress Effects on FosB- and Interleukin-8 (IL8)-driven Ovarian Cancer Growth and Metastasis* , 2010, The Journal of Biological Chemistry.

[66]  D. Schols,et al.  CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell mobilization. , 2010, Current pharmaceutical design.

[67]  M. Margolis,et al.  "The air got to it:" exploring a belief about surgery for lung cancer. , 2009, Journal of the National Medical Association.

[68]  K. Gelmon,et al.  Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[69]  M. Thornhill,et al.  Growth-regulated peptide-alpha (GRO-alpha) production by oral keratinocytes: a comparison with skin keratinocytes. , 2000, Cytokine.

[70]  T. Shien,et al.  A randomized controlled trial comparing primary tumour resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (PRIM-BC): Japan Clinical Oncology Group Study JCOG1017. , 2012, Japanese journal of clinical oncology.

[71]  H. Lee,et al.  Negative impact of leakage on survival of patients undergoing curative resection for advanced gastric cancer , 2011, Journal of surgical oncology.

[72]  D. Notterman,et al.  GROα Is Highly Expressed in Adenocarcinoma of the Colon and Down-Regulates Fibulin-1 , 2006, Clinical Cancer Research.

[73]  A. Widgerow Cellular/extracellular matrix cross‐talk in scar evolution and control , 2011, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[74]  R. Goris,et al.  Intestinal permeability is increased after major vascular surgery. , 1993, Journal of vascular surgery.

[75]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[76]  A. Mantovani,et al.  Granulocyte- and granulocyte– macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate , 1989, Nature.

[77]  N. Petrelli,et al.  Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[78]  J. Bono,et al.  FGF Receptor Inhibitors: Role in Cancer Therapy , 2012, Current Oncology Reports.

[79]  B. Goh Impact of laparoscopic resection for colorectal cancer on operative outcomes and survival. , 2007, Annals of surgery.

[80]  D. Dill,et al.  The Role of Interleukin-1 in Wound Biology. Part II: In Vivo and Human Translational Studies , 2010, Anesthesia and analgesia.

[81]  G. Ashcroft,et al.  Interleukin-6 and wound healing. , 1994, British journal of anaesthesia.

[82]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[83]  D. O'Leary,et al.  Less stress, more success? Oncological implications of surgery-induced oxidative stress , 2011, Gut.

[84]  B. Fisher,et al.  Experimental Evidence in Support of the Dormant Tumor Cell , 1959, Science.

[85]  L. Partridge,et al.  Vascular endothelial insulin/IGF-1 signaling controls skin wound vascularization. , 2012, Biochemical and biophysical research communications.

[86]  P. Venner Cytoreductive nephrectomy: a treatment of the past. , 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[87]  D. Waugh,et al.  The Interleukin-8 Pathway in Cancer , 2008, Clinical Cancer Research.

[88]  J. Bromberg,et al.  Targeting the interleukin-6/Jak/stat pathway in human malignancies. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[89]  C. Powers,et al.  Fibroblast growth factors, their receptors and signaling. , 2000, Endocrine-related cancer.

[90]  A. Darzi,et al.  A surgically induced hypoxic environment causes changes in the metastatic behaviour of tumours in vitro , 2006, Clinical & Experimental Metastasis.

[91]  Y. Carmi,et al.  Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions. , 2006, European journal of cancer.

[92]  Susana Linskens,et al.  Tyrosine isomers mediate the classical phenomenon of concomitant tumor resistance. , 2011, Cancer research.

[93]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[94]  K. Yamashita,et al.  Anastomotic Leakage Contributes to the Risk for Systemic Recurrence in Stage II Colorectal Cancer , 2010, Journal of Gastrointestinal Surgery.

[95]  C. McArdle,et al.  Impact of anastomotic leakage on long‐term survival of patients undergoing curative resection for colorectal cancer , 2005, The British journal of surgery.

[96]  S. Kelsey,et al.  Randomized Trial Comparing Locoregional Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at the Presentation (Protocol MF07‐01): A Study of Turkish Federation of the National Societies for Breast Diseases , 2009, The breast journal.

[97]  M. Durlik,et al.  Surgical Trauma Evokes a Rise in the Frequency of Hematopoietic Progenitor Cells and Cytokine Levels in Blood Circulation , 1998, European Surgical Research.

[98]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .

[99]  M. Cuesta,et al.  The surgical stress response and postoperative immune function after laparoscopic or conventional total mesorectal excision in rectal cancer: a randomized trial , 2010, International Journal of Colorectal Disease.

[100]  Carlos Arteaga,et al.  Targeting HER1/EGFR: a molecular approach to cancer therapy. , 2003, Seminars in oncology.

[101]  D. Bottaro,et al.  Targeting the HGF/Met signaling pathway in cancer therapy , 2012, Expert opinion on therapeutic targets.

[102]  K. Hamano,et al.  The influence of tumour resection on angiostatin levels and tumour growth--an experimental study in tumour-bearing mice. , 2001, European journal of cancer.

[103]  I. Pallister,et al.  Altered leucocyte progenitor profile in human bone marrow from patients with major trauma during the recovery phase , 2012, The British journal of surgery.

[104]  B. Aggarwal,et al.  Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. , 2012, Blood.

[105]  H. Dvorak Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[106]  C. V. D. van de Velde,et al.  Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[107]  D. Gouma,et al.  Tumor Progression After Preoperative Portal Vein Embolization , 2012, Annals of surgery.

[108]  F. Lozano,et al.  Bacterial translocation as a source of Dacron-graft contamination in experimental aortic operation: the importance of controlling SIRS. , 2006, Surgery.

[109]  R. Sylvester,et al.  Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial , 2001, The Lancet.

[110]  Aaron R Cooper,et al.  Intercohort Gene Expression Co-Analysis Reveals Chemokine Receptors as Prognostic Indicators in Ewing's Sarcoma , 2010, Clinical Cancer Research.

[111]  M Baum,et al.  The effects of surgery on tumor growth: a century of investigations. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[112]  Y. Okada,et al.  Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1–PI3K–Rac1 pathway , 2010, British Journal of Cancer.

[113]  C. Marijnen,et al.  Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[114]  P. Hanawalt,et al.  Direct evidence for spatial and temporal regulation of transforming growth factor β1 expression during cutaneous wound healing , 1991, Journal of cellular physiology.

[115]  S. Calderwood,et al.  Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers , 2012, Breast Cancer Research.

[116]  M. Koch,et al.  Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS - a randomised controlled multicentre trial (ISRCTN30964555) , 2012, BMC Cancer.

[117]  S. Brophy,et al.  Interventions for latent autoimmune diabetes (LADA) in adults. , 2011, The Cochrane database of systematic reviews.

[118]  A. Mirnezami,et al.  Increased Local Recurrence and Reduced Survival From Colorectal Cancer Following Anastomotic Leak: Systematic Review and Meta-Analysis , 2011, Annals of surgery.

[119]  Y. M. van der Linden,et al.  SUBMIT: Systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation , 2012, BMC Surgery.

[120]  J. Niland,et al.  Surgery of the primary tumor does not improve survival in stage IV breast cancer , 2011, Breast Cancer Research and Treatment.

[121]  M. Thornhill,et al.  GROWTH-REGULATED PEPTIDE-α (GRO-α) PRODUCTION BY ORAL KERATINOCYTES: A COMPARISON WITH SKIN KERATINOCYTES , 2000 .

[122]  M. Goebeler,et al.  Biphasic expression of stromal cell‐derived factor‐1 during human wound healing , 2007, The British journal of dermatology.

[123]  D. George,et al.  Platelet-derived growth factor receptors: a therapeutic target in solid tumors. , 2001, Seminars in oncology.

[124]  D. Galson,et al.  Monocyte chemotactic protein‐1 (MCP‐1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion , 2006, The Prostate.

[125]  B. Rollins,et al.  Wound Healing in MIP-1α−/− and MCP-1−/− Mice , 2001 .

[126]  N. Munshi,et al.  Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. , 2001, The New England journal of medicine.

[127]  G. Viani,et al.  Evaluation of biologic effective dose and schedule of fractionation for preoperative radiotherapy for rectal cancer: meta-analyses and meta-regression. , 2011, International journal of radiation oncology, biology, physics.

[128]  L. Nanney Epidermal and dermal effects of epidermal growth factor during wound repair. , 1990, The Journal of investigative dermatology.

[129]  D. Jonas,et al.  Expression of angiogenesis inhibitors in human bladder cancer may explain rapid metastatic progression after radical cystectomy. , 2009, International journal of molecular medicine.

[130]  L. Rubbia‐Brandt,et al.  ‘Liver First’ Approach in the Treatment of Colorectal Cancer with Synchronous Liver Metastases , 2009, Digestive Surgery.

[131]  R. Eils,et al.  Systemic spread is an early step in breast cancer. , 2008, Cancer cell.

[132]  K. Havenga,et al.  Preoperative Chemoradiotherapy with Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer. A Phase I–II Multicenter Study of the Dutch Colorectal Cancer Group , 2007, Annals of Surgical Oncology.

[133]  Xiaohong Yan,et al.  Plasma soluble vascular adhesion molecule-1 levels are persistently elevated during the first month after colorectal cancer resection , 2012, Surgical Endoscopy.

[134]  Theo Wobbes,et al.  Outgrowth of human liver metastases after resection of the primary colorectal tumor: A shift in the balance between apoptosis and proliferation , 2006, International journal of cancer.

[135]  C. Iacobuzio-Donahue,et al.  Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies , 2012, Cell.

[136]  Gina A. Taylor,et al.  Involvement of Follicular Stem Cells in Forming Not Only the Follicle but Also the Epidermis , 2000, Cell.

[137]  A. Bogdén,et al.  Proliferative response of human and animal tumours to surgical wounding of normal tissues: onset, duration and inhibition. , 1997, British Journal of Cancer.

[138]  R. Whelan,et al.  Minimally Invasive Colorectal Resection Is Associated With a Transient Increase in Plasma Hepatocyte Growth Factor Levels Early After Surgery for Colon Cancer , 2011, Surgical innovation.

[139]  M. Neeman,et al.  ©1999 Cancer Research Campaign Article no. bjoc.1998.0223 Stimulation of tumour growth by wound-derived growth , 2022 .

[140]  H. Lenz,et al.  Cancer Dormancy: A Model of Early Dissemination and Late Cancer Recurrence , 2011, Clinical Cancer Research.

[141]  Xiaohong Yan,et al.  Minimally invasive colon resection is associated with a persistent increase in plasma PlGF levels following cancer resection , 2011, Surgical Endoscopy.

[142]  R. Demicheli,et al.  Does surgery induce angiogenesis in breast cancer? Indirect evidence from relapse pattern and mammography paradox. , 2005, International journal of surgery.

[143]  Michael T. Lotze,et al.  Inflammation and necrosis promote tumour growth , 2004, Nature Reviews Immunology.

[144]  C. Alliot Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? , 2006, British Journal of Cancer.

[145]  Barbara L. Smith,et al.  Matched Pair Analyses of Stage IV Breast Cancer with or Without Resection of Primary Breast Site , 2008, Annals of Surgical Oncology.

[146]  J. Aguirre-Ghiso,et al.  Green Fluorescent Protein Tagging of Extracellular Signal-Regulated Kinase and p38 Pathways Reveals Novel Dynamics of Pathway Activation during Primary and Metastatic Growth , 2004, Cancer Research.